W. P. Arend and J. M. Dayer, Inhibition of the production and effects of interleukin-1 and tumor necrosis factor ? in rheumatoid arthritis, Arthritis Rheum, vol.38, pp.151-160, 1995.

M. Feldmann, F. M. Brennan, R. O. Williams, J. N. Woody, and R. N. Maini, The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis, Best Pract Res Clin Rheumatol, vol.18, pp.59-80, 2004.

P. J. Anderson, Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles, Semin Arthritis Rheum, vol.34, pp.19-22, 2005.

G. M. Bartelds, C. A. Wijbrandts, M. T. Nurmohamed, S. Stapel, W. F. Lems et al., Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis, Ann Rheum Dis, vol.66, pp.921-926, 2007.

M. Svenson, P. Geborek, T. Saxne, and K. Bendtzen, Monitoring patients treated with anti-TNF-? biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies, Rheumatology (Oxford), vol.46, pp.1828-1834, 2007.

M. E. Morgan, H. J. Witteveen, R. Sutmuller, R. De-vries, and R. Toes, CD25 + regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis, Hum Immunol, vol.65, pp.1319-1327, 2004.

M. E. Morgan, R. Flierman, L. M. Van-duivenvoorde, H. J. Witteveen, W. Van-ewijk et al., Effective treatment of collageninduced arthritis by adoptive transfer of CD25+ regulatory T cells, Arthritis Rheum, vol.52, pp.2212-2221, 2005.

H. Kelchtermans, D. Klerck, B. Mitera, T. Van-balen, M. Bullens et al., Defective CD4 + CD25 + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counterregulated by endogenous IFN-?, Arthritis Res Ther, vol.7, pp.402-415, 2005.

H. Kelchtermans, L. Geboes, T. Mitera, D. Huskens, G. Leclercq et al., Activated CD4 + CD25 + regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis, Ann Rheum Dis, vol.68, pp.744-750, 2009.

J. Biton, L. Semerano, L. Delavallée, D. Lemeiter, M. Laborie et al., Bessis N: Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis, J Immunol, vol.186, pp.3899-3910, 2011.

M. R. Ehrenstein, J. G. Evans, A. Singh, S. Moore, G. Warnes et al., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF? therapy, J Exp Med, vol.200, pp.277-285, 2004.

S. Nadkarni, C. Mauri, and M. R. Ehrenstein, Anti-TNF-? therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-?, J Exp Med, vol.204, pp.33-39, 2007.

H. Nie, Y. Zheng, R. Li, T. B. Guo, D. He et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-? in rheumatoid arthritis, Nat Med, vol.19, pp.322-328, 2013.

A. Thiolat, L. Semerano, Y. M. Pers, J. Biton, D. Lemeiter et al., IL-6 receptor blockade enhances CD39+ regulatory T-cell development in rheumatoid arthritis and in experimental arthritis, Arthritis Rheumatol, vol.66, pp.273-283, 2014.

F. Broere, L. Wieten, K. Koerkamp, E. I. Van-roon, J. A. Guichelaar et al., Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes, J Immunol, vol.181, pp.899-906, 2008.

M. J. Park, S. Y. Min, K. S. Park, Y. G. Cho, M. L. Cho et al., Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4 + CD25 + regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model, Arthritis Res Ther, vol.10, p.11, 2008.

C. G. Brunstein, J. S. Miller, Q. Cao, D. H. Mckenna, K. L. Hippen et al., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics, Blood, vol.117, pp.1061-1070, 2011.

D. Ianni, M. Falzetti, F. Carotti, A. Terenzi, A. Castellino et al., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, vol.117, pp.3921-3928, 2011.

P. Trzonkowski, M. Bieniaszewska, J. Ju?ci?ska, A. Dobyszuk, A. Krzystyniak et al., First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4 + CD25 + CD127 ? T regulatory cells, Clin Immunol, vol.133, pp.22-26, 2009.

H. Groux, A. O'garra, M. Bigler, M. Rouleau, S. Antonenko et al., A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, pp.737-742, 1997.

V. Brun, H. Bastian, V. Neveu, and A. Foussat, Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases, Int Immunopharmacol, vol.9, pp.609-613, 2009.

V. Brun, V. Neveu, Y. M. Pers, S. Fabre, B. Quatannens et al., Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood, Int Immunopharmacol, vol.11, pp.1074-1078, 2011.

P. Desreumaux, A. Foussat, M. Allez, L. Beaugerie, X. Hébuterne et al., Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease, Gastroenterology, vol.143, pp.1207-1217, 2012.

F. Cottrez, S. D. Hurst, R. L. Coffman, and H. Groux, T regulatory cells 1 inhibit a Th2-specific response in vivo, J Immunol, vol.165, pp.4848-4853, 2000.

F. J. Barrat, D. J. Cua, A. Boonstra, D. F. Richards, C. Crain et al., In vitro generation of interleukin 10-producing regulatory CD4 + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines, J Exp Med, vol.195, pp.603-616, 2002.

A. Foussat, F. Cottrez, V. Brun, N. Fournier, J. P. Breittmayer et al., A comparative study between T regulatory type 1 and CD4 + CD25 + T cells in the control of inflammation, J Immunol, vol.171, pp.5018-5026, 2003.

M. Battaglia, S. Gregori, R. Bacchetta, and M. G. Roncarolo, Tr1 cells: from discovery to their clinical application, Semin Immunol, vol.18, pp.120-127, 2006.

N. Gagliani, C. F. Magnani, S. Huber, M. E. Gianolini, M. Pala et al., Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells, Nat Med, vol.19, pp.739-746, 2013.

G. E. Osman, S. Cheunsuk, S. E. Allen, C. E. Liggitt, H. D. Hood et al., Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice, Int Immunol, vol.10, pp.1613-1622, 1998.

M. Battaglia, A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori et al., Induction of tolerance in type 1 diabetes via both CD4 + CD25 + T regulatory cells and T regulatory type 1 cells, Diabetes, vol.55, pp.1571-1580, 2006.

M. Camps, T. Rückle, H. Ji, V. Ardissone, F. Rintelen et al., Blockade of PI3K? suppresses joint inflammation and damage in mouse models of rheumatoid arthritis, Nat Med, vol.11, pp.936-943, 2005.

L. M. Charbonnier, W. G. Han, J. Quentin, T. W. Huizinga, J. Zwerina et al., Adoptive transfer of IL-10-secreting CD4 + CD49b + regulatory T cells suppresses ongoing arthritis, J Autoimmun, vol.34, pp.390-399, 2010.

C. F. Magnani, G. Alberigo, R. Bacchetta, G. Serafini, M. Andreani et al., Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells, Eur J Immunol, vol.41, pp.1652-1662, 2011.

J. A. Hill, M. Feuerer, K. Tash, S. Haxhinasto, J. Perez et al., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature, Immunity, vol.27, pp.786-800, 2007.

J. M. Weiss, A. M. Bilate, M. Gobert, Y. Ding, M. C. De-lafaille et al., Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3 + T reg cells, J Exp Med, vol.209, pp.1723-1742, 2012.

M. Yadav, C. Louvet, D. Davini, J. M. Gardner, M. Martinez-llordella et al., Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo, J Exp Med, vol.209, pp.1713-1722, 2012.

L. M. Khachigian, Collagen antibody-induced arthritis, Nat Protoc, vol.1, pp.2512-2516, 2006.

S. Sakaguchi and N. Sakaguchi, Animal models of arthritis caused by systemic alteration of the immune system, Curr Opin Immunol, vol.17, pp.589-594, 2005.

M. Kavousanaki, A. Makrigiannakis, D. Boumpas, and P. Verginis, Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy, Arthritis Rheum, vol.62, pp.53-63, 2010.

J. B. Wing and S. Sakaguchi, TCR diversity and Treg cells, sometimes more is more, Eur J Immunol, vol.41, pp.3097-3100, 2011.

B. Seddon and D. Mason, Peripheral autoantigen induces regulatory T cells that prevent autoimmunity, J Exp Med, vol.189, pp.877-882, 1999.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells, J Exp Med, vol.203, pp.1701-1711, 2006.

N. Kong, Q. Lan, M. Chen, J. Wang, W. Shi et al., Antigen-specific transforming growth factor ?-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance, Arthritis Rheum, vol.64, pp.2548-2558, 2012.

F. Apparailly, C. Verwaerde, C. Jacquet, C. Auriault, J. Sany et al., Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis, J Immunol, vol.160, pp.5213-5220, 1998.

L. A. Joosten, E. Lubberts, P. Durez, M. M. Helsen, M. J. Jacobs et al., Role of interleukin-4 and interleukin-10 in murine collageninduced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction, Arthritis Rheum, vol.40, pp.249-260, 1997.

Y. Ma, S. Thornton, L. E. Duwel, G. P. Boivin, E. H. Giannini et al., Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer, J Immunol, vol.161, pp.1516-1524, 1998.

J. D. Whalen, E. L. Lechman, C. A. Carlos, K. Weiss, I. Kovesdi et al., Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws, J Immunol, vol.162, pp.3625-3632, 1999.

S. Persson, A. Mikulowska, S. Narula, A. O'garra, and R. Holmdahl, Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats, Scand J Immunol, vol.44, pp.607-614, 1996.

Y. Tanaka, T. Otsuka, T. Hotokebuchi, H. Miyahara, H. Nakashima et al., Effect of IL-10 on collagen-induced arthritis in mice, Inflamm Res, vol.45, pp.283-288, 1996.

M. Walmsley, P. D. Katsikis, E. Abney, S. Parry, R. O. Williams et al., Interleukin-10 inhibition of the progression of established collageninduced arthritis, Arthritis Rheum, vol.39, pp.495-503, 1996.

E. Lubberts, L. A. Joosten, L. Van-den-bersselaar, M. M. Helsen, A. C. Bakker et al., Van Den Berg WB: Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw, Clin Exp Immunol, vol.120, pp.375-383, 2000.

S. Gregori, K. S. Goudy, and M. G. Roncarolo, The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells, Front Immunol, vol.3, p.30, 2012.

M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis et al., Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells, J Exp Med, vol.199, pp.1567-1575, 2004.

M. Mandapathil, M. J. Szczepanski, M. Szajnik, J. Ren, E. K. Jackson et al., Adenosine and prostaglandin E 2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells, J Biol Chem, vol.285, pp.27571-27580, 2010.

. Asnagli, Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis, Arthritis Research & Therapy, vol.16, p.115, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01870451